| Literature DB >> 30397667 |
Anne Stey1, Joni Ricks-Oddie2, Sheila Innis3, Shawn J Rangel4, R Lawrence Moss5, Bruce L Hall6,7,8, Albert Dibbins9, Erik D Skarsgard3.
Abstract
OBJECTIVE: WHO uses anthropometric classification scheme of childhood acute and chronic malnutrition based on low body mass index (BMI) ('wasting') and height for age ('stunting'), respectively. The goal of this study was to describe a novel two-axis nutritional classification scheme to (1) characterise nutritional profiles in children undergoing abdominal surgery and (2) characterise relationships between preoperative nutritional status and postoperative morbidity.Entities:
Keywords: children’s surgery; malnutrition; outcomes; risk-adjustment
Year: 2018 PMID: 30397667 PMCID: PMC6203011 DOI: 10.1136/bmjpo-2018-000303
Source DB: PubMed Journal: BMJ Paediatr Open ISSN: 2399-9772
Figure 1(A, B) Children from 29 days to 18 years were divided into five nutritional profile groups based on the WHO and the Centre for Disease Control (CDC) growth curve algorithms and plotted by their assigned body mass index (BMI) Z-score along the Y axis and height Z-score along the X axis. Children outside of two Z-scores in any direction were categorised as an outlier nutritional profile group. (A) Children under 2 years of age using the WHO algorithm to assign Z-scores. (B) Children 2 years of age and older using the CDC algorithm to assign Z-scores.
Preoperative patient specific clinical variables and comorbidities by nutritional profile group
| Preoperative clinical variables | Underweight short n=656 | Overweight short n=733 | Underweight tall n=252 | Overweight tall n=1534 | Normal | P values* |
| Inpatient status | 585 (89.2) | 591 (80.6) | 210 (83.3) | 1142 (74.5) | 20 280 (75.5) | <0.0001 |
| Case status | <0.0001 | |||||
| Elective | 498 (76.0) | 411 (56.1) | 98 (38.9) | 1240 (80.8) | 14 431 (53.7) | |
| Urgent | 87 (13.3) | 151 (20.6) | 54 (21.4) | 124 (8.1) | 4851 (18.1) | |
| Emergent | 71 (10.9) | 171 (23.3) | 100 (39.7) | 170 (11.1) | 7580 (28.2) | |
| Male gender | 405 (61.7) | 453 (61.8) | 156 (61.9) | 969 (63.2) | 14 911 (55.5) | <0.0001 |
| Race | 0.0003 | |||||
| Caucasian | 491 (79.2) | 567 (81.9) | 185 (76.1) | 1240 (81.5) | 21 283 (83.8) | |
| African-American | 110 (17.7) | 105 (15.2) | 49 (20.2) | 239 (15.7) | 3289 (13.0) | |
| Asian | 18 (2.9) | 18 (2.6) | 9 (3.7) | 33 (2.2) | 661 (2.6) | |
| Native American | 1 (0.2) | 2 (0.3) | 0 | 8 (0.5) | 120 (0.5) | |
| Hispanic | 63 (9.6) | 132 (18.0) | 40 (15.9) | 199 (13.0) | 4054 (15.1) | 0.04 |
| Age | <0.0001 | |||||
| 29–364 days | 308 (47.0) | 225 (30.7) | 95 (37.7) | 840 (54.8) | 5069 (18.9) | |
| 1–2 years | 32 (4.9) | 127 (17.3) | 13 (5.2) | 508 (33.1) | 1431 (5.3) | |
| 3–5 years | 53 (8.1) | 122 (16.6) | 61 (24.2) | 24 (1.6) | 3007 (11.2) | |
| 6–7 years | 32 (4.9) | 45 (6.1) | 36 (14.3) | 31 (2.0) | 2117 (7.9) | |
| 8–12 years | 97 (14.9) | 114 (15.6) | 38 (15.1) | 83 (5.4) | 6980 (26.0) | |
| 13–18 years | 134 (20.4) | 100 (13.6) | 9 (3.6) | 48 (3.1) | 8258 (30.7) | |
| Premature birth | 170 (25.9) | 94 (12.8) | 14 (5.6) | 261 (17.0) | 2276 (8.5) | <0.0001 |
| Metabolic and nutritional conditions | ||||||
| Nutritional support | 253 (38.6) | 139 (19.0) | 29 (11.5) | 286 (18.6) | 2515 (9.4) | <0.0001 |
| Greater than 10% weight loss within 6 months | 286 (43.6) | 72 (9.8) | 37 (14.7) | 155 (10.1) | 1823 (6.8) | <0.0001 |
| Renal conditions | ||||||
| Acute renal failure | 5 (0.8) | 3 (0.4) | 2 (0.8) | 11 (0.7) | 126 (0.5) | 0.27 |
| American Society of Anesthesiologists class | ||||||
| I | 33 (5.0) | 181 (24.7) | 74 (29.4) | 275 (17.9) | 7904 (29.4) | <0.0001 |
| II | 147 (22.4) | 261 (35.6) | 111 (44.1) | 673 (43.9) | 12 044 (44.8) | |
| III | 407 (62.0) | 251 (34.2) | 59 (23.4) | 514 (33.5) | 6294 (23.4) | |
| IV | 65 (9.9) | 39 (5.3) | 6 (2.4) | 66 (4.3) | 591 (2.2) | |
| V | 4 (0.6) | 1 (0.1) | 2 (0.8) | 6 (0.4) | 29 (0.1) | |
| Gastrointestinal conditions | ||||||
| Oesophageal gastrointestinal disease | 436 (66.5) | 331 (45.2) | 100 (39.7) | 743 (48.4) | 8821 (32.8) | <0.0001 |
| Hepatobiliary disease | 35 (5.3) | 36 (4.9) | 5 (2.0) | 76 (5.0) | 2321 (8.6) | <0.0001 |
| Cardiovascular conditions | ||||||
| Cardiac risk factors | <0.0001 | |||||
| Mild cardiac risk factors | 103 (15.7) | 73 (10.0) | 5 (2.0) | 173 (11.3) | 1444 (5.4) | |
| Moderate cardiac risk factors | 55 (8.4) | 42 (5.7) | 6 (2.4) | 72 (4.7) | 693 (2.6) | |
| Severe cardiac risk factors | 26 (4.0) | 14 (1.9) | 1 (0.4) | 45 (2.9) | 280 (1.0) | |
| Cardiac surgery | 81 (12.4) | 56 (7.6) | 9 (3.6) | 127 (8.3) | 1086 (4.0) | <0.0001 |
| Neurological conditions | ||||||
| Cerebrovascular accident | 42 (6.4) | 30 (4.1) | 5 (2.0) | 63 (4.1) | 509 (1.9) | <0.0001 |
| Seizure disorder | 124 (18.9) | 65 (8.9) | 20 (7.9) | 72 (4.7) | 1110 (4.1) | <0.0001 |
| Cerebral palsy | 112 (17.1) | 22 (3.0) | 8 (3.2) | 16 (1.0) | 516 (1.9) | <0.0001 |
| Neuromuscular disorder | 77 (11.7) | 45 (6.1) | 12 (4.8) | 59 (3.9) | 844 (3.1) | <0.0001 |
| Developmental delay | 263 (40.1) | 147 (20.1) | 26 (10.3) | 249 (16.2) | 2786 (10.4) | <0.0001 |
| Central nervous system structural abnormality | 127 (19.4) | 75 (10.2) | 14 (5.6) | 156 (10.2) | 1296 (4.8) | <0.0001 |
| Haematological and immunological conditions | ||||||
| Bleeding disorder | 11 (1.7) | 9 (1.2) | 0 (0) | 16 (1.0) | 223 (0.8) | 0.025 |
| Steroid use within 30 days | 37 (5.6) | 33 (4.5) | 4 (1.6) | 50 (3.3) | 918 (3.4) | 0.007 |
| Immune disease | 18 (2.7) | 18 (2.5) | 0 (0) | 19 (1.2) | 615 (2.3) | 0.69 |
| Haematological disorder | 64 (9.8) | 37 (5.1) | 8 (3.2) | 73 (4.8) | 1396 (5.2) | 0.001 |
| Bone marrow transplant | 4 (0.6) | 2 (0.3) | 0 | 6 (0.4) | 79 (0.3) | 0.33 |
| Transplantation | 4 (0.6) | 4 (0.6) | 0 | 3 (0.2) | 147 (0.6) | 0.61 |
| Preoperative red blood cell transfusion | 25 (3.8) | 19 (2.6) | 5 (2.0) | 23 (1.5) | 384 (1.4) | <0.0001 |
| Pulmonary conditions | ||||||
| Asthma | 43 (6.6) | 70 (9.6) | 7 (2.8) | 81 (5.3) | 1665 (6.2) | 0.12 |
| Chronic lung disease | 92 (14.0) | 56 (7.6) | 5 (2.0) | 112 (7.3) | 856 (3.2) | <0.0001 |
| Cystic fibrosis | 8 (1.2) | 4 (0.6) | 1 (0.4) | 7 (0.5) | 181 (0.7) | 0.52 |
| Structural pulmonary abnormality | 83 (12.7) | 64 (8.7) | 11 (4.4) | 130 (8.5) | 1078 (4.0) | <0.0001 |
| Oxygen supplementation | 70 (10.7) | 53 (7.2) | 10 (4.0) | 96 (6.3) | 691 (2.6) | <0.0001 |
| Tracheostomy | 18 (2.7) | 30 (4.1) | 3 (1.2) | 37 (2.4) | 264 (1.0) | <0.0001 |
| Acuity of condition | ||||||
| Prior surgery within 30 days | 31 (4.7) | 22 (3.0) | 10 (4.0) | 39 (2.5) | 530 (2.0) | <0.0001 |
| Open wound | 22 (3.4) | 13 (1.8) | 4 (1.6) | 40 (2.6) | 538 (2.0) | 0.07 |
| Cardiopulmonary resuscitation | 2 (0.3) | 3 (0.4) | 1 (0.4) | 2 (0.1) | 28 (0.1) | 0.006 |
| Do not resuscitate | 2 (0.3) | 0 | 0 | 1 (0.1) | 21 (0.1) | 0.35 |
| Inotropic support | 15 (2.3) | 7 (1.0) | 2 (0.8) | 11 (0.7) | 179 (0.7) | <0.0001 |
| Preoperative sepsis within 48 hours | <0.0001 | |||||
| No sepsis | 620 (94.5) | 645 (88.0) | 205 (81.4) | 1452 (94.7) | 23 022 (85.7) | |
| Systemic inflammatory response syndrome | 17 (2.6) | 38 (5.2) | 16 (6.4) | 36 (2.4) | 1980 (7.4) | |
| Sepsis | 13 (2.0) | 47 (6.4) | 31 (12.3) | 39 (2.5) | 1799 (6.7) | |
| Septic shock | 6 (0.9) | 3 (0.4) | 0 (0) | 7 (0.5) | 61 (0.2) | |
*Derived from χ2 test of preoperative patient-specific clinical variables among nutritional profile groups.
Unadjusted rates of postoperative 30-day complication by nutritional profile group
| Postoperative 30-day complications | Underweight short n=656 | Overweight short n=733 | Underweight tall n=252 | Overweight tall n=1534 | Normal | P values* |
| Surgical-site infection | 13 (2.0) | 34 (4.6) | 6 (2.4) | 41 (2.7) | 913 (3.4) | 0.31 |
| Postoperative sepsis | 16 (2.4) | 6 (0.8) | 1 (0.4) | 26 (1.7) | 224 (0.8) | 0.0002 |
| Return to operating room | 32 (4.9) | 39 (5.3) | 5 (2.0) | 64 (4.2) | 769 (2.9) | <0.0001 |
| Dehiscence | 4 (0.6) | 6 (0.8) | 3 (1.2) | 10 (0.7) | 111 (0.4) | 0.03 |
| Transfusion within 72 hours | 16 (2.4) | 7 (1.0) | 3 (1.2) | 19 (1.2) | 162 (0.6) | <0.0001 |
| Reintubation | 16 (2.4) | 5 (0.7) | 3 (1.2) | 7 (0.5) | 106 (0.4) | <0.0001 |
| Acute renal failure | 2 (0.3) | 2 (0.3) | 0 (0) | 3 (0.2) | 34 (0.1) | 0.18 |
| Central line-associated infection | 3 (0.5) | 1 (0.1) | 0 | 6 (0.4) | 51 (0.2) | 0.24 |
| Pneumonia | 8 (1.2) | 7 (1.0) | 2 (0.8) | 7 (0.5) | 135 (0.5) | 0.01 |
| Cardiac arrest | 3 (0.5) | 1 (0.1) | 1 (0.4) | 5 (0.3) | 35 (0.1) | 0.02 |
| Deep vein thrombosis | 1 (0.2) | 1 (0.1) | 1 (0.4) | 4 (0.3) | 56 (0.2) | 0.82 |
| Urinary tract infections | 4 (0.6) | 5 (0.7) | 0 (0) | 11 (0.7) | 155 (0.6) | 0.84 |
| Mortality | 4 (0.6) | 3 (0.4) | 1 (0.4) | 5 (0.3) | 51 (0.2) | 0.005 |
| Composite 30-day morbidity | 66 (10.1) | 61 (8.3) | 20 (7.9) | 107 (7.0) | 1634 (6.1) | <0.0001 |
| Healthcare-associated infections | 34 (5.2) | 46 (6.3) | 9 (3.6) | 79 (5.2) | 1287 (4.8) | 0.18 |
| Reintervention events | 48 (7.3) | 43 (5.9) | 8 (3.2) | 71 (4.6) | 881 (3.3) | <0.0001 |
*Derived from a χ2 test comparing complications among nutritional profile group.
Multivariate logistic regression predicting composite 30-day morbidity
| OR* | 95% CI* | P values* | |
| Composite morbidity current procedural terminology linear risk | 0.38 | 0.36 to 0.40 | <0.0001 |
| Age | 0.99 | 0.98 to 1.00 | 0.07 |
| American Society of Anaesthesiologists class | 1.02 | 1.00 to 1.04 | 0.06 |
| Underweight short | 1.35 | 1.03 to 1.75 | 0.04 |
| Overweight short | 1.43 | 1.06 to 1.89 | 0.01 |
| Underweight tall | 1.32 | 0.81 to 2.22 | 0.30 |
| Overweight tall | 1.00 | 0.81 to 1.25 | 0.97 |
Both composite 30-day morbidity current procedural terminology linear risk and age were continuous variables.
*Derived from Proc Mianalyze following multiple imputation of the four nutritional profile groups using Proc Glimmix.
Multivariate logistic regression predicting composite healthcare-associated infections
| OR* | 95% CI* | P values* | |
| Composite healthcare-associated infection current procedural terminology linear risk | 0.33 | 0.30 to 0.36 | <0.0001 |
| Age | 0.98 | 0.97 to 0.99 | 0.0001 |
| American Society of Anaesthesiologists class | 1.05 | 1.02 to 1.08 | <0.0001 |
| Underweight short | 0.89 | 0.60 to 1.33 | 0.56 |
| Overweight short | 1.43 | 1.05 to 1.92 | 0.02 |
| Underweight tall | 0.75 | 0.37 to 1.52 | 0.42 |
| Overweight tall | 1.15 | 0.90 to 1.45 | 0.27 |
Both composite healthcare-associated infection current procedural terminology linear risk and age were continuous variables.
*Derived from Proc Mianalyze following multiple imputation of the four nutritional profile groups using Proc Glimmix.
Multivariate logistic regression predicting composite reintervention events
| OR* | 95% CI* | P values* | |
| Composite reintervention events current procedural terminology linear risk | 0.34 | 0.31 to 0.36 | <0.0001 |
| Age | 0.99 | 0.98 to 1.00 | 0.28 |
| American Society of Anaesthesiologists class | 1.01 | 0.98 to 1.01 | 0.35 |
| Underweight short | 1.75 | 1.28 to 2.38 | 0.001 |
| Overweight short | 1.79 | 1.30 to 2.50 | 0.001 |
| Underweight tall | 0.99 | 0.47 to 2.08 | 0.97 |
| Overweight tall | 1.08 | 0.82 to 1.41 | 0.58 |
Both composite reintervention events current procedural terminology linear risk and age were continuous variables.
*Derived from Proc Mianalyze following multiple imputation of the four nutritional profile groups using Proc Glimmix.